Protective Effects of Melatonin and Mitochondria-targeted Antioxidants Against Oxidative Stress: A Review - PubMed (original) (raw)

Review

Protective Effects of Melatonin and Mitochondria-targeted Antioxidants Against Oxidative Stress: A Review

M R Ramis et al. Curr Med Chem. 2015.

Abstract

Oxidative damage is related to aging and a wide range of human disorders. Mitochondria are in large part responsible for free radical production and they are also main targets of the attack of these toxic molecules. The resulting deleterious effects of the damage to mitochondria can be prevented by antioxidants. Melatonin is an endogenously-produced indoleamine that modulates numerous functions, including mitochondria-related functions; this result from its capacity to penetrate all morphophysiological barriers and to enter all subcellular compartments due to its amphiphilic nature. Furthermore, this indoleamine and its metabolites are powerful antioxidants and scavengers of free radicals, protecting cellular membranes, the electron transport chain and mitochondrial DNA from oxidative damage. These properties may make melatonin a potent protector against a variety of free radical-related diseases. By comparison, other conventional antioxidants have less efficacy due to their limited access to the mitochondria. In recent years, research has focused on the advancement of mitochondria-targeted antioxidants, such as MitoQ (composed by the lipophilic triphenylphosphonium cation conjugated to the endogenous antioxidant coenzyme Q10) and MitoE (composed by the triphenylphosphonium cation attached to the antioxidant α-tocopherol). Mitochondria-targeted antioxidants accumulate in several hundred-fold greater concentrations within mitochondria and protect these critical organelles from oxidative damage. Melatonin also seems to be a mitochondria-targeted antioxidant and has similar protective actions as the synthetic antioxidants. Further work is required to determine the therapeutic properties of these antioxidants in ameliorating diseases related to mitochondrial dysfunction.

PubMed Disclaimer

Cited by

Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders.
Melhuish Beaupre LM, Brown GM, Gonçalves VF, Kennedy JL. Melhuish Beaupre LM, et al. Transl Psychiatry. 2021 Jun 2;11(1):339. doi: 10.1038/s41398-021-01464-x. Transl Psychiatry. 2021. PMID: 34078880 Free PMC article. Review.
Endogenous Generation of Singlet Oxygen and Ozone in Human and Animal Tissues: Mechanisms, Biological Significance, and Influence of Dietary Components.
Onyango AN. Onyango AN. Oxid Med Cell Longev. 2016;2016:2398573. doi: 10.1155/2016/2398573. Epub 2016 Mar 6. Oxid Med Cell Longev. 2016. PMID: 27042259 Free PMC article. Review.
Melatonin in Retinal Physiology and Pathology: The Case of Age-Related Macular Degeneration.
Blasiak J, Reiter RJ, Kaarniranta K. Blasiak J, et al. Oxid Med Cell Longev. 2016;2016:6819736. doi: 10.1155/2016/6819736. Epub 2016 Sep 5. Oxid Med Cell Longev. 2016. PMID: 27688828 Free PMC article. Review.
Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders.
Galano A, Guzmán-López EG, Reiter RJ. Galano A, et al. Int J Mol Sci. 2021 Oct 27;22(21):11584. doi: 10.3390/ijms222111584. Int J Mol Sci. 2021. PMID: 34769013 Free PMC article. Review.
Melatonin improves age-induced fertility decline and attenuates ovarian mitochondrial oxidative stress in mice.
Song C, Peng W, Yin S, Zhao J, Fu B, Zhang J, Mao T, Wu H, Zhang Y. Song C, et al. Sci Rep. 2016 Oct 12;6:35165. doi: 10.1038/srep35165. Sci Rep. 2016. PMID: 27731402 Free PMC article.

Protective Effects of Melatonin and Mitochondria-targeted Antioxidants Against Oxidative Stress: A Review - PubMed (original) (raw)